300+ Clinical Trials, 0 FDA Approved Cardiac Stem Cell Therapies

About Us

Cellular Logistics is an early stage venture based on research at WIMR at the UW-Madison

Explore

Products

Cellogicus™ is a cell delivery platform for regenerative medicine therapeutics.

Explore

Technology

Cellular Logistic’s biomaterial is derived from the culture of human cardiac fibroblasts

Explore

Cellogicus™ significantly increases cell survival rates and retention of regenerative medicine therapeutics in the target area or organ.

Explore